Recent Finacing
Recent Raise
Genome Profiling develops GenProEpiMarkers using proprietary analytics to convert NGS epigenetic data into precision assays for clinical-trial responder selection, companion diagnostics, and earlier disease diagnosis, informing translational medicine.
Focus Areas
Recent Investors
Funding round
Investor